Oplev Flexidrip 0.5% Infusion
Marketer
Otsuka Pharmaceutical India Pvt Ltd
Salt Composition
Levofloxacin (0.5% w/v)
Overview Oplev Flexidrip 0.5% Infusion
Flexidrip 0.5% Infusion, an intravenous antibiotic called Oplev, combats bacterial infections. Its applications include urinary tract, respiratory (including pneumonia), skin, soft tissue, and throat infections. This medication halts bacterial proliferation, thus resolving the infection. Administered intravenously by medical personnel only (due to its injectable nature), it's reserved for patients unable to take oral medication, such as those hospitalized or unconscious. Complete the prescribed dosage; premature cessation can hinder treatment. Common side effects include headache, dizziness, nausea, and constipation. While diarrhea may occur, it typically resolves with treatment completion; persistent diarrhea or bloody stools necessitate immediate medical attention. Injection site reactions (pain, swelling, redness) are possible but usually transient. However, prolonged symptoms warrant consultation. Prior allergies to any component necessitate avoidance. Individuals with kidney issues require close monitoring during treatment.
Uses of Oplev Flexidrip 0.5% Infusion
Combating Bacterial Infections
Major Benefits of Oplev Flexidrip 0.5% Infusion:
This medication will be administered by your healthcare provider. Self-medication is not advised.
Common Side effects of Oplev Flexidrip 0.5% Infusion:
- Injection site reactions (pain, swelling, redness)
- Headache
- Dizziness
- Nausea
- Constipation
- Diarrhea
How to use Oplev Flexidrip 0.5% Infusion:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Oplev Flexidrip 0.5% Infusion works:
Flexidrip 0.5% Infusion, an antibiotic solution, inactivates the bacterial enzyme DNA-gyrase. This halts bacterial cell division and repair mechanisms, resulting in bacterial cell death.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Oplev Flexidrip 0.5% Infusion poses no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Oplev Flexidrip 0.5% Infusion during pregnancy is contraindicated due to confirmed risks to fetal development. In exceptional, life-threatening circumstances, a physician might consider its use only if the potential benefits outweigh the known hazards. Patient consultation with their physician is essential.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while using Oplev Flexidrip 0.5% Infusion is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Oplev Flexidrip 0.5% Infusion can induce drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving is prohibited should these effects manifest.
KidneyCAUTION
Exercise caution when administering Oplev Flexidrip 0.5% Infusion to individuals with impaired renal function. Dosage modification of Oplev Flexidrip 0.5% Infusion might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Oplev Flexidrip 0.5% Infusion to individuals with hepatic impairment. Physician consultation is recommended. Discontinue use and notify your physician immediately if jaundice manifests during treatment.
What if you forget to take Oplev Flexidrip 0.5% Infusion :
Should you forget a dose of Oplev Flexidrip 0.5% Infusion, seek medical advice.
Facts to Know About Oplev Flexidrip 0.5% Infusion
| Label | Value |
|---|---|
| Chemical Category | Quinolone antibiotic |
| Developing Good Habits | No. |
| Type of Therapy | Antimicrobial Agents |
| Actions | Fluoroquinolone antibiotics |
3,018 People bought this recently